Skip to main content
. 2003 Feb;47(2):541–547. doi: 10.1128/AAC.47.2.541-547.2003

FIG. 3.

FIG. 3.

Mean (and SD) piperacillin concentration-time profile during intermittent infusion (piperacillin, 4 g; tazobactam, 0.5 g; every 6 h) and continuous infusion (piperacillin, 16 g; tazobactam, 2 g; over 24 h) with the MM model. The solid line represents the fit with the MM model based on the intermittent pharmacokinetic data.